Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Mesothelioma, Malignant
×
tumor necrosis factor-alpha, CNGRC fusion protein, human
×
Clear all
Filters
3
NCT00484276
2019-01-16
NGR010
AGC Biologics S.p.A.
Phase 2
Completed
57 enrolled
NCT01358084
2019-01-15
NGR019
AGC Biologics S.p.A.
Phase 2
Completed
137 enrolled